Biomarkers for cardiovascular disease
Platelets as biomarkers for cardiovascular disease The development of a point-of-care biomarker counter is a breakthrough in medical technology, making it possible for the first time in history to measure platelet activity quickly, easily and at low cost. Activated platelets and specific coagulation factors can be a prediction of an approaching heart attack, thrombosis or …